DrugPatentWatch Database Preview

Ajanta Pharma Ltd Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?

AJANTA PHARMA LTD has fifty-one approved drugs.

There are three tentative approvals on AJANTA PHARMA LTD drugs.

Summary for Ajanta Pharma Ltd

US Patents:	0
Tradenames:	41
Ingredients:	40
NDAs:	51
Drug Master File Entries:	2
Patent Litigation for Ajanta Pharma Ltd:	See patent lawsuits for Ajanta Pharma Ltd

Drugs and US Patents for Ajanta Pharma Ltd

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ajanta Pharma Ltd	IRBESARTAN	irbesartan	TABLET;ORAL	203685-001	Dec 10, 2015		DISCN	No	No
Ajanta Pharma Ltd	AMLODIPINE AND OLMESARTAN MEDOXOMIL	amlodipine besylate; olmesartan medoxomil	TABLET;ORAL	207216-001	Oct 28, 2016	AB	RX	No	No
Ajanta Pharma Ltd	ARIPIPRAZOLE	aripiprazole	TABLET;ORAL	206174-002	Sep 12, 2016	AB	RX	No	No
Ajanta Pharma Ltd	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	203957-002	Oct 14, 2016		DISCN	No	No
Ajanta Pharma Ltd	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	CAPSULE;ORAL	212624-004	Sep 13, 2019	AB	RX	No	No
Ajanta Pharma Ltd	TETRABENAZINE	tetrabenazine	TABLET;ORAL	213621-001	Dec 4, 2020		DISCN	No	No
Ajanta Pharma Ltd	CAPTOPRIL	captopril	TABLET;ORAL	212809-003	Dec 13, 2019	AB	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Ajanta Pharma Ltd